The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia.
Agnieszka MatuszewskaKrzysztof KowalskiPaulina JawieńTomasz TomkalskiDagmara Gaweł-DąbrowskaAnna Merwid-LądEwa SzelągKarolina BłaszczakBenita WiatrakMaciej WłodarczykJanusz PiasnyAdam SzelągPublished in: International journal of molecular sciences (2023)
Schizophrenia is a severe mental disorder with a chronic, progressive course. The etiology of this condition is linked to the interactions of multiple genes and environmental factors. The earlier age of onset of schizophrenia, the higher frequency of negative symptoms in the clinical presentation, and the poorer response to antipsychotic treatment in men compared to women suggests the involvement of sex hormones in these processes. This article aims to draw attention to the possible relationship between testosterone and some clinical features in male schizophrenic patients and discuss the complex nature of these phenomena based on data from the literature. PubMed, Web of Science, and Google Scholar databases were searched to select the papers without limiting the time of the publications. Hormone levels in the body are regulated by many organs and systems, and take place through the neuroendocrine, hormonal, neural, and metabolic pathways. Sex hormones play an important role in the development and function of the organism. Besides their impact on secondary sex characteristics, they influence brain development and function, mood, and cognition. In men with schizophrenia, altered testosterone levels were noted. In many cases, evidence from available single studies gave contradictory results. However, it seems that the testosterone level in men affected by schizophrenia may differ depending on the phase of the disease, types of clinical symptoms, and administered therapy. The etiology of testosterone level disturbances may be very complex. Besides the impact of the illness (schizophrenia), stress, and antipsychotic drug-induced hyperprolactinemia, testosterone levels may be influenced by, i.a., obesity, substances of abuse (e.g., ethanol), or liver damage.
Keyphrases
- bipolar disorder
- drug induced
- replacement therapy
- liver injury
- middle aged
- public health
- multiple sclerosis
- chronic kidney disease
- end stage renal disease
- type diabetes
- newly diagnosed
- oxidative stress
- dna methylation
- metabolic syndrome
- sleep quality
- gene expression
- electronic health record
- drinking water
- white matter
- working memory
- genome wide
- ejection fraction
- insulin resistance
- transcription factor
- combination therapy
- body mass index
- mesenchymal stem cells
- machine learning
- patient reported outcomes
- mild cognitive impairment
- peritoneal dialysis
- deep learning